Inovio Pharma (INO)
1.09
+0.19 (21.11%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
August 13, 2026 7:04 AM - StreetInsider
Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy
August 13, 2026 4:37 AM - StreetInsider
Inovio Pharma (INO) Tops Q2 EPS by 18c
August 12, 2026 4:38 PM - StreetInsider
Form 8-K INOVIO PHARMACEUTICALS, For: Aug 12
August 12, 2026 4:08 PM - SEC Filing
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026 4:05 PM - PR NewsWire
Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
August 12, 2026 4:01 PM - SEC Filing
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
August 12, 2026 12:03 PM - SEC Filing
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
August 7, 2026 4:14 PM - SEC Filing
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: FMR LLC
August 6, 2026 10:32 AM - SEC Filing
INOVIO to Report Second Quarter Financial Results on August 12, 2026
August 4, 2026 4:05 PM - PR NewsWire
Inovio Pharmaceuticals (INO) PT Lowered to $4 at Piper Sandler
August 3, 2026 8:14 AM - StreetInsider
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:20 AM - SEC Filing
Form 8-K INOVIO PHARMACEUTICALS, For: Jul 29
July 31, 2026 7:23 AM - SEC Filing
Form 424B5 INOVIO PHARMACEUTICALS,
July 30, 2026 5:27 PM - SEC Filing
Inovio prices $20 million public offering at $0.95 per share
July 29, 2026 8:54 PM - StreetInsider
INOVIO Announces Pricing of $20.0 Million Public Offering
July 29, 2026 8:54 PM - PR NewsWire
Form 8-K INOVIO PHARMACEUTICALS, For: Jul 29
July 29, 2026 4:04 PM - SEC Filing
Form 424B5 INOVIO PHARMACEUTICALS,
July 29, 2026 4:01 PM - SEC Filing
Inovio Pharmaceuticals plans public offering of stock and warrants
July 29, 2026 4:01 PM - StreetInsider
INOVIO Announces Proposed Public Offering
July 29, 2026 4:01 PM - PR NewsWire
Form EFFECT INOVIO PHARMACEUTICALS,
July 13, 2026 6:02 AM - SEC Filing
Inovio Pharma (INO) files $300M mixed shelf
July 2, 2026 4:05 PM - StreetInsider
Form S-3 INOVIO PHARMACEUTICALS,
July 2, 2026 4:03 PM - SEC Filing
Inovio Pharmaceuticals (INO) PT Lowered to $2.50 at H.C. Wainwright
June 1, 2026 6:54 AM - StreetInsider
INOVIO to Participate in Upcoming Scientific and Investor Conferences
May 28, 2026 8:05 AM - PR NewsWire
Form S-8 INOVIO PHARMACEUTICALS,
May 26, 2026 6:02 AM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: YARNO WENDY L
May 21, 2026 4:51 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Shepard Jay
May 21, 2026 4:32 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Miller Ann Calby
May 21, 2026 4:12 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Weiner David B.
May 21, 2026 4:11 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Zoth Lota S.
May 21, 2026 4:11 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: DANSEY ROGER D
May 21, 2026 4:07 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: BENITO SIMON X
May 21, 2026 4:07 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Humeau Laurent
May 21, 2026 4:06 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Sumner Michael John
May 21, 2026 4:06 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: KIES PETER
May 21, 2026 4:05 PM - SEC Filing
Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Shea Jacqueline Elizabeth
May 21, 2026 4:05 PM - SEC Filing
ApolloBio reports positive phase 3 results for INOVIO's VGX-3100
May 21, 2026 4:05 PM - StreetInsider
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
May 21, 2026 4:05 PM - PR NewsWire
Form 8-K INOVIO PHARMACEUTICALS, For: May 19
May 20, 2026 4:02 PM - SEC Filing
Full Article List
